AFYREN Revenue and Competitors
Estimated Revenue & Valuation
- AFYREN's estimated annual revenue is currently $12.7M per year.
- AFYREN's estimated revenue per employee is $155,000
Employee Data
- AFYREN has 82 Employees.
- AFYREN grew their employee count by 5% last year.
AFYREN's People
| Name | Title | Email/Phone |
|---|
AFYREN Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is AFYREN?
AFYREN industrialises innovative processes worldwide, with the aim of producing without waste, natural molecules usually petro-sourced, used to manufacture everyday products (food, cosmetics, agronomy), while respecting the environment. The non-food biomass transformed by the AFYNERIE ® process produces synthons (from 2 to 6 carbons) that will lead via green chemistry to a range of high value-added molecules.
keywords:N/A
N/A
Total Funding
82
Number of Employees
$12.7M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AFYREN News
Xinyu Sanyang, Tianguan, SEKAB, Godavari, AFYREN, Wacker Chemie, ZeaChem, Lenzing,. Up to. Grain & Sugar Fermentation, Wood Cellulose...
AFYREN (Paris:ALAFY), a Greentech company that offers manufacturers biobased, low-carbon products created with technology based on natural...
AFYREN NEOXY is the first industrial-scale plant for the production of biobased carboxylic acids from sugar beet co-products. Today, the...
Other Companies in Clermont-Ferrand
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.6M | 85 | 8% | N/A |
#2 | N/A | 92 | 30% | N/A |
#3 | $25.2M | 120 | 12% | N/A |
#4 | $21.4M | 134 | 2% | N/A |
#5 | N/A | 137 | 11% | N/A |